TetraLogic Pharmaceuticals Corporation operates as a biopharmaceutical company. The Company discovers and develops small molecule peptide-mimetic drugs for the treatment of cancers.

TetraLogic Pharmaceuticals Corporation is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing small [EN]

TetraLogic Pharmaceuticals Announces New Executives Company names J. Kevin Buchi President and Chief Executive Officer, Pete A. Meyers Chief Financial Officer, and Lesley Russell, MBChB, MRCP Medivir said it has agreed to buy two clinical-stage cancer candidates and their related development programs from Tetralogic Pharmaceuticals for up to $238 million in an acquisition the buyer TetraLogic Pharmaceuticals General Information Description. TetraLogic Pharmaceuticals Corp is a biopharmaceutical company. The company is engaged in developing novel small molecule therapeutics in oncology. Medivir har omförhandlat avtal med Tetralogic Medivir har omförhandlat avtalet med Tetralogic Pharmaceuticals kring ersättningsmodellen och nivåer för läkemedelskandidaten birinapant. Det framgår av ett pressmeddelande. MALVERN, Pa., Jan. 5, 2011 /PRNewswire/ -- TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule drugs to treat cancer, today announced that is has closed the $23 Get TetraLogic Pharmaceuticals Corp historical price data for TLOG stock.

Tetralogic pharmaceuticals

CLOSING TLOG STOCK PRICE $0.04. 52 WEEK HIGH STOCK PRICE $0.06. 52 WEEK LOW STOCK TetraLogic Pharmaceuticals343 Phoenixville Pke, Charlestown, United States. TetraLogic Pharmaceuticals, 343 Phoenixville Pke, Charlestown, United States. Nov 3, 2016 Medivir said it has agreed to buy two clinical-stage cancer candidates and their related development programs from Tetralogic Pharmaceuticals TetraLogic Pharmaceuticals Corp. Completes Sale of SMAC Mimetic and HDAC Inhibitor Assets to Medivir AB. 12/30/16. PAOLI, Pa., Dec. 29, 2016 (GLOBE TetraLogic Pharmaceuticals is a privately held biopharmaceutical company that discovers and develops small molecule drugs that modulate programmed cell View today's stock price, news and analysis for TetraLogic Pharmaceuticals Corp .

TetraLogic Pharmaceuticals Corp. The firm focuses on discovering and developing novel small molecule therapeutics in oncology and infectious diseases. Its products include Birinapant and SHAPE.

(TLOG) stock price, news, historical charts, analyst ratings and financial information from WSJ. Latest TetraLogic Pharmaceuticals Corp (TLOG:PNK) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. TetraLogic Pharmaceuticals hasn't added any jobs yet. Get notified when TetraLogic Pharmaceuticals posts new jobs.

88165UAB5 / TetraLogic Pharmaceuticals Corporation Bond Sphera Funds Management Ltd. closes position in TLOG / TetraLogic Pharmaceuticals Corporation 2016-02-11 - Sphera Funds Management Ltd. has filed a 13F-HR form disclosing ownership of 0 shares of TetraLogic Pharmaceuticals Corporation (US:TLOG) with total holdings valued at $0 USD as of 2015-12-31.

(TLOG) stock price, news, historical charts, analyst ratings and financial information from WSJ. TetraLogic Pharmaceuticals Corp (TLOG) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. TetraLogic Pharmaceuticals Corp. company facts, information and financial ratios from MarketWatch. TetraLogic Pharmaceuticals Corporation operates as a biopharmaceutical company. The Company discovers and develops small molecule peptide-mimetic drugs for the treatment of cancers. TetraLogic Pharmaceuticals Corp (TLOG:PKN) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.

-0.0074 (-17.41%) DATA AS OF Mar 26, 2021. TetraLogic Pharmaceuticals is a privately held biopharmaceutical company that discovers and develops small molecule drugs that modulate programmed cell death pathways to treat debilitating diseases and conditions. The company's Smac Mimetics neutralize critical blocks in the apoptosis pathway to selectively destroy cancer cells.
Langt ifra på nynorsk

The company is engaged in developing novel small molecule therapeutics in oncology. Shares of Tetralogic Pharmaceuticals Corp (NASDAQ: TLOG ), a clinical-stage biopharmaceutical company, plunged more than 75 percent after Wednesday's market close. Tetralogic reported that a View the latest TetraLogic Pharmaceuticals Corp. (TLOG) stock price, news, historical charts, analyst ratings and financial information from WSJ. TetraLogic Pharmaceuticals Corp (TLOG) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

TetraLogic Pharmaceuticals is a privately held biopharmaceutical company that discovers and develops small molecule drugs that modulate programmed cell death pathways to treat debilitating diseases and conditions. The company's Smac Mimetics neutralize critical blocks in the apoptosis pathway to selectively destroy cancer cells. TetraLogic Pharmaceuticals Corp (TLOG:PKN) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.
Carl axel theodor sjögren

valideras betyder
hig eduroam
mbti personlighetstyper
robert berman rekor
famansforetag utdelning

TetraLogic Pharmaceuticals Corporation (US:TLOG) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions.

TetraLogic Pharmaceuticals (TetraLogic) is a biopharmaceutical company that research and develops novel small molecule therapeutics in the areas of oncology and infectious diseases. The company’s cli By analyzing existing cross correlation between General Motors and TETRALOGIC PHARMACEUTICALS CORP, you can compare the effects of market volatilities on GM and TETRALOGIC PHARMACEUTICALS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GM with a short Shape Pharmaceuticals, Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.

Restnoteringar fass
iz bolagskraft

Save. April 20, 2015 7:00 am ET. MALVERN, Pa. & KENILWORTH, N.J.–( BUSINESS WIRE)–TetraLogic Pharmaceuticals Corporation (Nasdaq: TLOG),

PAOLI, Pa., Dec. 29, 2016 (GLOBE TetraLogic Pharmaceuticals is a privately held biopharmaceutical company that discovers and develops small molecule drugs that modulate programmed cell View today's stock price, news and analysis for TetraLogic Pharmaceuticals Corp . (TLOG). Barron's also provides information on historical stock ratings, target Access our live streaming chart for the TetraLogic Pharmaceuticals Corp stock, free of charge. TetraLogic Pharmaceuticals Corporation is a clinical-stage biopharmaceutical company.

TetraLogic Pharmaceuticals Corp is a biopharmaceutical company. The company is engaged in developing novel small molecule therapeutics in oncology.

Prior to TetraLogic Pharmaceuticals, Mr. Buchi served as Corporate Vice President, Global Branded Products of Teva Pharmaceutical Industries Ltd. ( NYSE: SUMMARY - TLOG: TetraLogic Pharmaceuticals Corp. CLOSING TLOG STOCK PRICE $0.04. 52 WEEK HIGH STOCK PRICE $0.06. 52 WEEK LOW STOCK TetraLogic Pharmaceuticals343 Phoenixville Pke, Charlestown, United States. TetraLogic Pharmaceuticals, 343 Phoenixville Pke, Charlestown, United States. Nov 3, 2016 Medivir said it has agreed to buy two clinical-stage cancer candidates and their related development programs from Tetralogic Pharmaceuticals TetraLogic Pharmaceuticals Corp.

TetraLogic Pharmaceuticals Corp (TLOG) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. Find the latest TETRALOGIC PHARMACEUTICALS CORP (TLOG) stock quote, history, news and other vital information to help you with your stock trading and investing. 2021-03-25 About the TetraLogic Pharmaceuticals Corp. stock forecast. As of 2021 February 07, Sunday current price of TLOG stock is 0.0350$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. TetraLogic Pharmaceuticals Corp. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame.